Pharmacophore and QSAR modeling of estrogen receptor β ligands and subsequent validation and in silico search for new hits
Authors:
- Mutasem O. TahaMutasem O. Taha
- Mai TarairahMTMai Tarairah
- Hiba ZalloumHZHiba Zalloum
- Ghassan Abu-SheikhaGAGhassan Abu-Sheikha
- 1 January 2010
- journal article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 28 (5) , 383-400
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- ERβ ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor β-selective ligandsBioorganic & Medicinal Chemistry Letters, 2007
- Estrogen receptor β ligands: Design and synthesis of new 2-phenyl-isoindole-1,3-dionesBioorganic & Medicinal Chemistry Letters, 2007
- Indazole Estrogens: Highly Selective Ligands for the Estrogen Receptor βJournal of Medicinal Chemistry, 2005
- Understanding the Selectivity of Genistein for Human Estrogen Receptor-β Using X-Ray Crystallography and Computational MethodsStructure, 2004
- Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β LigandsJournal of Medicinal Chemistry, 2004
- ERβ Ligands. Part 2: Synthesis and structure–activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivativesBioorganic & Medicinal Chemistry, 2004
- Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human DiseaseEndocrinology, 2003
- ERβ Ligands. Part 1: The discovery of ERβ selective ligands which embrace the 4-hydroxy-biphenyl templateBioorganic & Medicinal Chemistry, 2003
- Structure and mechanism of the oestrogen receptorBiochemical Society Transactions, 2003
- Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999